Literature DB >> 7586730

Lupus: key pathogenic mechanisms and contributing factors.

C Mohan1, S K Datta.   

Abstract

The past 30 years of research on murine and human systemic lupus erythematosus has served to identify an array of immunological aberrations--some shared, some unique, some primary, others secondary-- that may underlie this disease. In integrating these findings, it appears that at least four distinct pathogenic events characterize lupus: (1) Anti-DNA Abs and immune complexes induce renal damage; (2) B-cells produce pathogenic anti-DNA antibodies; (3) Th cells drive lupus B-cells; and (4) Increased concentrations and abnormal presentation of nucleosomes. The purpose of this review is to examine the roles of these four events in the pathogenesis of lupus and to identify the different factors that can precipitate these pathogenic events.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586730     DOI: 10.1006/clin.1995.1146

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  16 in total

1.  Physical and biological studies on DNA/anti-DNA immune complex formed in vitro.

Authors:  Y Gao; P Wang; A Tajima; M Matsumura
Journal:  Cytotechnology       Date:  1997-11       Impact factor: 2.058

Review 2.  T cells of lupus and molecular targets for immunotherapy.

Authors:  S K Datta; A Kaliyaperumal; A Desai-Mehta
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

Review 3.  Genetic dissection of lupus nephritis in murine models of SLE.

Authors:  E K Wakeland; L Morel; C Mohan; M Yui
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

4.  Antinuclear autoantibodies in patients with inflammatory bowel disease. High prevalence in first-degree relatives.

Authors:  C Folwaczny; N Noehl; S P Endres; W Heldwein; K Loeschke; H Fricke
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

5.  Cochlear involvement in patients with systemic autoimmune rheumatic diseases: a clinical and laboratory comparative study.

Authors:  Georgios K Tsirves; Paraskevi V Voulgari; Eleftherios Pelechas; Asimakis D Asimakopoulos; Alexandros A Drosos
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-30       Impact factor: 2.503

6.  Prevalence and features of metabolic syndrome in childhood-onset systemic lupus erythematosus.

Authors:  Nailú Angélica Sinicato; Mariana Postal; Karina de Oliveira Peliçari; Leticia Rittner; Roberto Marini; Simone Appenzeller
Journal:  Clin Rheumatol       Date:  2017-04-19       Impact factor: 2.980

7.  Altered X-chromosome inactivation in T cells may promote sex-biased autoimmune diseases.

Authors:  Camille M Syrett; Bam Paneru; Donavon Sandoval-Heglund; Jianle Wang; Sarmistha Banerjee; Vishal Sindhava; Edward M Behrens; Michael Atchison; Montserrat C Anguera
Journal:  JCI Insight       Date:  2019-04-04

8.  Anti-subnucleosome reactivities in systemic lupus erythematosus (SLE) patients and their first-degree relatives.

Authors:  C Mohan; F Liu; C Xie; R C Williams
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

9.  Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.

Authors:  M R J Green; A S M Kennell; M J Larche; M H Seifert; D A Isenberg; M R Salaman
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

10.  Pathogenesis of autoimmunity in alphabeta T cell-deficient lupus-prone mice.

Authors:  S L Peng; J Cappadona; J M McNiff; M P Madaio; M J Owen; A C Hayday; J Craft
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.